WHO ICTRP trial
The efficacy of intravenous bolus Dexmedetomidine and mepridine on the treatment…
IRCT20150125020795N4 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20150125020795N4 |
|---|---|
| Public title | The efficacy of intravenous bolus Dexmedetomidine and mepridine on the treatment of shivering following general anesthesia |
| Scientific title | Comparing the efficacy of intravenous bolus Dexmedetomidine and mepridine on the treatment of shivering following general anesthesia |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Shivering following general anesthesia. Other complications of anesthesia;T88.5 |
| Interventions | Intervention 1: Intervention group: In the intervention group, dexmedomidine (Imagen-Iran) will be used 1 µg / kg body weight. Intervention 2: Control group: The control group will receive 10 mg of pethidine (Exir - Iran). |
| Registration date | Oct 4, 2019 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: